Risk factors measured in middle-aged men predicting coronary events in geriatric age

Alessandro Menotti1, Paolo Emilio Puddu2

  • 1Association for Cardiac Research, - Associazione per la Ricerca Cardiologica, Rome, Italy.

Insights

Major coronary risk factors predict heart disease for 30-40 years. A single measurement of factors like smoking and blood pressure remains significant into older age.

Area of Science:

  • Cardiology
  • Epidemiology
  • Preventive Medicine

Background:

  • Coronary heart disease (CHD) poses a significant public health challenge.
  • Identifying the long-term predictive power of traditional risk factors is crucial for effective prevention strategies.

Purpose of the Study:

  • To determine how long major coronary risk factors, measured once in middle-aged men, predict the incidence and mortality of coronary heart disease (CHD).
  • To analyze the predictive duration over a 50-year follow-up period.

Main Methods:

  • Utilized data from 1677 CHD-free men (aged 40-59) from the Italian Rural Areas of the Seven Countries Study, enrolled in 1960.
  • Measured baseline age, cigarette smoking, systolic blood pressure, and serum cholesterol.
  • Employed partitioned Cox proportional hazards models for sequential 10-year periods over 50 years of follow-up.

Main Results:

  • Risk factors like smoking, blood pressure, and cholesterol showed increasing predictive trends for CHD incidence and mortality for the first 30-40 years.
  • A decline in predictive association was observed after 30-40 years, particularly for serum cholesterol.
  • Model analysis confirmed a loss of predictive power beyond 30-40 years, even with interaction terms.

Conclusions:

  • A single assessment of major coronary risk factors retains predictive association with CHD incidence and mortality for at least 30-40 years.
  • These risk factors remain relevant into the gerontologic age, underscoring the importance of long-term risk assessment.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
340
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
308
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
305
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
798
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
298